Tag: HeartLight X3
US FDA approval granted for HeartLight X3 endoscopic ablation system
CardioFocus has announced that the US Food and Drug Administration (FDA) has approved the next-generation HeartLight X3 endoscopic ablation system for the treatment of...
CardioFocus submits HeartLight X3 PMA application to FDA
CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...
HeartLight expands its availability to more than 100 hospitals globally
The HeartLight Endoscopic Ablation System is now offered at more than 100 hospitals worldwide. CardioFocus highlighted the expanded availability of its catheter ablation technology...
Results announced from study with the HeartLight X3 system
CardioFocus recently announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 system for the treatment of AFib. The results...
Heartlight X3 gains European CE Mark
CardioFocus has announced the European CE Mark approval for its HeartLight X3 endoscopic ablation system, used in the treatment of atrial fibrillation.
The HeartLight X3 system...
CardioFocus completes enrolment in HeartLight X3 trial
CardioFocus has completed enrolment in a trial to evaluate its next-generation HeartLight X3 endoscopic ablation system. According to a press release, a total of...